EUVIMEDEUVIMED entdecken
Open Access

Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain

Prachi Dilipkumar Trivedi, Sarojini Posani, Neeharika Balla, Mohommed Mujtaba Sheezan, Ayesha Salim Hussain, Roshni Xavier, Kachhadia Meet Popatbhai, Mohammed Abdul Mateen, Priyadarshi Prajjwal, Mohammed Dheyaa Marsool Marsool

Bioinformation · 30.04.2024 · 20 (4) · 386-390

DOI: 10.6026/973206300200386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 30.04.2024. Verfasst von Prachi Dilipkumar Trivedi und 9 weiteren Autor:innen. Beteiligte Einrichtung: GMERS Medical College, Himmatnagar, Gujarat , India. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain largely influences the well-being of patients. Anticonvulsant and antidepressant medications, such as Pregabalin, Gabapentin, and Amitriptyline, are routinely prescribed as initial treatments for neuropathic pain. The study sample has a total of 270 patients who meet the inclusion criteria and are further distributed into three equally sized groups (A, B, and C). Group A was administered with Gabapentine 300mg, Group B with Pregabalin 75 mg, and Amitriptyline 10 mg to Group C. The occurrence of any adverse drug response was documented using the ADR reporting form, while the pain of the patient's post-medication was recorded using a numerical pain rating scale (NPRS). The comparison of the NPRS scores of all three groups "by using ANOVA test" both at baseline and after 15 days reveal that the differences between the three groups are statistically insignificant (p > 0.089). However, after one month of continuous use, the difference becomes slightly significant (I.e., p = 0.003). Gabapentin, pregabalin, and amitriptyline demonstrate similar effectiveness in alleviating neuropathic (NeP) pain. The study concludes that gabapentin is superior to both pregabalin and amitriptyline with fewer adverse effects, leading to improved patient adherence for long-term use.

Schlagwörter

Stichwörter der Autor:innen

Nerve painanxietydepressiongabapentinpregabalinspinal cord injuries

Autor:innen und Institutionen

  • GMERS Medical College, Himmatnagar, Gujarat , India.
  • Dr. Parveen Multi-speciality Clinic, Kothagudem, India.
  • Maharajah's Institute of Medical Sciences, Vizianagaram, India.
  • Medical University of Lodz , Poland.
  • Medical Officer, Ziva hospital, Kharar, Chandigarh.
  • Medical Officer at Carewell Hospital, Padapparamba, Malappuram, Kerala , India.

Zitieren

APA

Trivedi, P. D., Posani, S., Balla, N., Sheezan, M. M., Hussain, A. S., Xavier, R., Popatbhai, K. M., Mateen, M. A., Prajjwal, P., & Marsool Marsool, M. D. (2024). Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain. Bioinformation, 20(4), 386-390. https://doi.org/10.6026/973206300200386

Vancouver

Trivedi PD, Posani S, Balla N, Sheezan MM, Hussain AS, Xavier R, et al. Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain. Bioinformation. 2024;20(4):386-390. doi:10.6026/973206300200386

BibTeX
@article{Trivedi2024,
  author = {Trivedi, Prachi Dilipkumar and Posani, Sarojini and Balla, Neeharika and Sheezan, Mohommed Mujtaba and Hussain, Ayesha Salim and Xavier, Roshni and Popatbhai, Kachhadia Meet and Mateen, Mohammed Abdul and Prajjwal, Priyadarshi and Marsool Marsool, Mohammed Dheyaa},
  title = {Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain},
  journal = {Bioinformation},
  year = {2024},
  volume = {20},
  number = {4},
  pages = {386--390},
  doi = {10.6026/973206300200386}
}
Kostenlos starten →